Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors

Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
Journal of Nuclear Medicine December 2022, 63 (12) 1865-1870; DOI: https://doi.org/10.2967/jnumed.122.263984
Eric Ouvrard
1Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis De Mestier
2Department of Pancreatology and Digestive Oncology, ENETS Centre of Excellence, Beaujon Hospital, Université de Paris, and INSERM U1149, Centre of Research in Inflammation, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Boursier
3Nuclear Medicine, University Hospital of Nancy, Nancy, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boumediene Lachachi
4Nuclear Medicine, Hospices Civils de Lyon, Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Sahakian
5Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elodie Chevalier
3Nuclear Medicine, University Hospital of Nancy, Nancy, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nidaa Mikail
6Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital, Université de Paris, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefina Carullo
1Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France;
7Nuclear Medicine, Sanatorio Allende S.A., Cordoba, Argentina;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélie Bando-Delaunay
6Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital, Université de Paris, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Walter
8Medical Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Lyon 1, Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel G. Malouf
9Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pietro Addeo
10Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Hospitals of Strasbourg, Strasbourg, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Poncet
11Digestive and Oncologic Surgery, Edouard-Herriot University Hospital, Claude-Bernard Lyon 1 University, Lyon, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Sebag
12Endocrine Surgery, Conception University Hospital, Aix-Marseille University, Marseille, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachida Lebtahi
6Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital, Université de Paris, Paris, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Goichot
13Diabetes and Metabolic Disorders, Internal Medicine, University Hospitals of Strasbourg, Strasbourg University, Strasbourg, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Taïeb
5Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France;
14European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessio Imperiale
1Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France;
15Molecular Imaging–DRHIM, IPHC, UMR 7178, CNRS/Unistra, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Correlation of surgical exploration and 18F-DOPA PET/CT findings in patient with grade 1 SiNETs and metastatic mesenteric lymph nodes of groups 2 and 3 according to Pasquer et al. (7).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Head-to-head comparison between 68Ga-DOTATOC (A and C) and 18F-DOPA PET/CT (B and D) in oligometastatic patient with bifocal SiNETs (*). 68Ga-DOTATOC PET/CT failed to detect hepatic and peritoneal metastases (dotted arrows), visible only on 18F-DOPA PET/CT (solid arrows). SUV-bw = (PET image pixel value) * (weight in grams) / (injected dose).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Patient Population and Tumor Characteristics

    CharacteristicData
    Patients53 (100%)
    Women31 (58%)
    Age (y)65 (13)
    PET/CT indication
     Suspicion of SiNETs15 (28%)
     Staging of histologically proven metastatic SiNETs38 (72%)
    World Health Organization grade, 2019
     123 (43%)
     225 (47%)
     33 (6%)
    Ki-675.8 (8.7) (median, 3.7)
    Biochemical tumor markers
     Elevated serum CgA28 (53%)
     Elevated 24-h urinary 5-HIAA14 (26%)
    Long-acting somatostatin analogs13 (25%)
    • Qualitative data are number and percentage; continuous data are median and SD.

    • View popup
    TABLE 2.

    Comparison Between 68Ga-DOTATOC and 18F-DOPA PET/CT for Primary SiNETs and Metastases (DR): Per-Lesion Analysis

    Parameter68Ga-DOTATOC18F-DOPALesionsDiscordant patientsP
    All primary SiNETs106 (91%)103 (88%)117140.549
    Excised primary SiNETs58 (76%)53 (70%)76*120.275
    Primary multifocality6 (75%)6 (75%)8 (100%)51.000
    All metastases694 (81%)811 (95%)85538<0.001
    Subdiaphragmatic LN165 (90%)178 (97%)184140.009
     Mesenteric LN58 (88%)67 (100%)6770.003
     Mesenteric LN, group 114 (88%)16 (100%)1620.157
     Mesenteric LN, group 233 (92%)36 (100%)3630.317
     Mesenteric LN, group 311 (79%)15 (100%)1530.046
    Liver312 (87%)353 (99%)35712<0.001
    Peritoneum53 (47%)107 (96%)11212<0.001
    Lung13 (50%)26 (100%)264<0.001
    Bone98 (84%)100 (86%)11670.732
    Supradiaphragmatic LN30 (81%)28 (76%)37100.617
    Left supraclavicular LN23 (100%)19 (83%)2330.046
    • ↵* 76 primary SiNETs detected at histology (sensitivity) in 37 surgically treated patients.

    • LN = lymph nodes.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (12)
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb, Alessio Imperiale
Journal of Nuclear Medicine Dec 2022, 63 (12) 1865-1870; DOI: 10.2967/jnumed.122.263984

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb, Alessio Imperiale
Journal of Nuclear Medicine Dec 2022, 63 (12) 1865-1870; DOI: 10.2967/jnumed.122.263984
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe detude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Show more Clinical Investigation

Similar Articles

Keywords

  • 68Ga-DOTATOC
  • 18F-DOPA
  • PET
  • neuroendocrine
  • small intestine
  • carcinoid
  • staging
SNMMI

© 2025 SNMMI

Powered by HighWire